The global veterinary point of care diagnostics market size was valued at USD 2.3 billion in 2025 and is projected to grow from USD 2.51 billion in 2026 to USD 5.13 billion by 2034, registering a CAGR of 9.32% during the forecast period from 2026 to 2034. North America dominated the veterinary point of care diagnostics market with a market share of 40.5% in 2025.
Veterinary point-of-care diagnostics are diagnostic tests and devices used to detect, monitor, and evaluate diseases and health conditions in animals directly at veterinary clinics, hospitals, farms, and other care settings. These solutions provide rapid results from samples such as blood, urine, and other biological fluids, supporting timely diagnosis and treatment decisions. Veterinary point-of-care diagnostics include blood analyzers, imaging and testing devices, infectious disease tests, and other rapid diagnostic technologies used for companion animals and livestock.
Download a Free Sample To learn more about this report,
Growing Adoption of AI-Based In-Clinic Cytology
The veterinary point of care diagnostics market is increasingly incorporating artificial intelligence into cytology workflows that previously depended heavily on specialist interpretation. Digital imaging combined with AI can analyze cellular samples inside veterinary practices and provide standardized results while the animal is still at the clinic. Faster interpretation can help veterinarians make treatment decisions without sending every specimen to an external laboratory. AI-supported cytology is therefore becoming an important part of veterinary point of care diagnostics market trends.
In January 2026, IDEXX Laboratories expanded its inVue Dx Cellular Analyzer with AI-supported applications for veterinary cytology. The platform can deliver results in approximately 10 minutes and uses a reference database containing more than 5 million annotated cellular images.
Increasing Development of Portable Molecular Diagnostics
Veterinary molecular testing is moving closer to animals through compact systems capable of detecting pathogen DNA or RNA outside centralized laboratories. Portable PCR-based technologies can help veterinarians identify infectious diseases rapidly and initiate treatment, isolation, or herd-management measures without waiting for samples to travel to reference facilities. This is particularly valuable for livestock, equine, and field veterinary applications. Decentralized molecular testing is consequently expanding the veterinary point of care diagnostics industry beyond conventional clinic-based analyzers.
In May 2025, Biomeme expanded its portable veterinary molecular-testing capabilities through its Franklin real-time PCR platform, which weighs approximately 1.2 kg and supports 9 reaction wells with multiplex detection of as many as 27 targets in a single instrument run.
Increasing Veterinary Visits Are Raising Demand for Immediate Test Results
Veterinarians frequently need chemistry, hematology, urinalysis, and other diagnostic information during consultations to distinguish diseases with similar clinical signs. Point-of-care testing reduces dependence on sample transportation and allows diagnosis and treatment planning to occur within the same visit. Faster results are particularly valuable in emergency cases and when animals require immediate medication or surgery. Increasing diagnostic intensity in veterinary practice is therefore strengthening veterinary point of care diagnostics market demand.
In August 2025, Mars Veterinary Health expanded diagnostic and clinical capabilities across its network of approximately 3,000 veterinary clinics and hospitals, illustrating the scale of veterinary infrastructure requiring rapid diagnostic support during routine and emergency care.
High Consumable Costs Can Limit Testing Volumes in Smaller Practices
Point-of-care analyzers require recurring expenditure on cartridges, slides, reagents, controls, and other proprietary consumables in addition to the initial equipment investment. Small veterinary practices may process relatively few samples, making the per-test economics less attractive than sending non-urgent specimens to centralized laboratories. Consumables can also expire if testing volumes are insufficient. Cost-per-test considerations can consequently restrain veterinary point of care diagnostics market growth among lower-volume clinics.
In February 2026, Zoetis expanded its Vetscan point-of-care ecosystem across chemistry, hematology, and diagnostic-imaging workflows, with its VS2 chemistry analyzer using single-use reagent rotors capable of generating results from approximately 100 µL of sample.
Expansion of Point-of-Care Testing for Livestock Reproductive Management
Livestock producers need rapid information about reproductive status to optimize breeding schedules, calving intervals, and herd productivity. Point-of-care hormone testing can allow veterinarians and producers to make reproductive decisions without waiting for laboratory turnaround, creating a separate application from infectious-disease diagnosis. Reproductive diagnostics can therefore help suppliers increase veterinary point of care diagnostics market share.
In June 2026, IDEXX competitor Advanced Animal Diagnostics expanded livestock point-of-care testing applications for reproductive and herd-management workflows, with portable systems designed to provide actionable results during the farm visit rather than after laboratory shipment.
Maintaining Reliable Results Across Multiple Animal Species
Diagnostic values can vary substantially among dogs, cats, horses, cattle, and other animals because each species has different reference intervals, cellular characteristics, and biomarker concentrations. A test developed around one species cannot automatically provide equivalent clinical accuracy in another. Manufacturers therefore need species-specific validation, calibration, reference data, and quality controls while keeping systems practical for everyday veterinary use. Maintaining consistent diagnostic performance across diverse animals remains a major challenge as veterinary point of care diagnostics market size expands.
In September 2025, Fujifilm expanded its DRI-CHEM NX600V veterinary chemistry platform supporting multiple animal species. The analyzer can process up to 5 samples simultaneously and perform as many as 128 tests per hour, illustrating the combination of throughput and species-specific testing required in veterinary diagnostics.
Companion Animal Segment Dominated the Market with 64.8% Share in 2025
The strong position of companion animals reflects growing demand for accessible and timely veterinary diagnostics. Pet owners are increasingly seeking preventive care and rapid diagnostic evaluation, encouraging veterinary practices to adopt point-of-care testing that can support faster clinical decision-making.
Request Customizationto receive a tailored report.
Consumables, Reagents, and Kits Segment Dominated the Market with 68.4% Share in 2025
The widespread use of consumables, reagents, and diagnostic kits supports their leading position in veterinary point-of-care diagnostics. These products are routinely required for testing and are replenished as diagnostic procedures are performed, creating consistent demand across veterinary settings.
Blood/Plasma/Serum Segment Dominated the Market with 54.7% Share in 2025
Blood, plasma, and serum samples are widely used for veterinary diagnostic testing because they can provide information across multiple clinical conditions. Their broad applicability in routine examinations and disease assessment continues to support their prominent position.
The virology segment is Expected to Grow at the Fastest CAGR of 10.15% During the Forecast Period
Increasing attention to viral diseases in animal populations is supporting demand for rapid and accessible virology testing. Point-of-care diagnostic capabilities can help veterinarians identify infections more efficiently and support timely treatment and disease-management decisions.
Infectious Disease Segment Dominated the Market with 52.8% Share in 2025
The high share of infectious disease testing reflects the importance of rapid identification and management of infections in veterinary care. Point-of-care diagnostics can provide results closer to the time of consultation, helping veterinarians make faster clinical decisions.
Home Care Settings Segment is Expected to Grow at the Fastest CAGR of 10.6% During the Forecast Period
The expansion of home-based animal care is creating opportunities for convenient diagnostic testing outside traditional veterinary facilities. Greater emphasis on continuous monitoring and accessible pet healthcare is encouraging the use of point-of-care diagnostic solutions in home care environments.
Speak to an Analystto discuss market opportunities.
The North American veterinary point of care diagnostics market accounted for 40.5% of the global market, reaching USD 0.93 billion in 2025. The region holds the largest market share, supported by advanced veterinary healthcare infrastructure, high pet healthcare spending, increasing adoption of rapid diagnostic technologies, and growing demand for convenient testing at veterinary clinics.
The United States represents a major market in North America. Its established veterinary healthcare infrastructure, large companion animal population, and increasing adoption of rapid diagnostic solutions continue to support market growth.
Canada's developed veterinary healthcare system, growing pet ownership, and increasing use of advanced diagnostic technologies continue to support regional market development.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific veterinary point of care diagnostics market accounted for 22.6% of the global market, reaching USD 0.52 billion in 2025, and is projected to grow at the fastest CAGR of 11.25% during the forecast period. Increasing pet ownership, expanding veterinary infrastructure, rising animal healthcare expenditure, and growing adoption of rapid diagnostic technologies are driving regional market development.
China represents a major market within the Asia Pacific. Rising companion animal ownership, expanding veterinary services, and increasing awareness of animal healthcare continue to support demand for point of care diagnostic solutions.
Japan's established veterinary healthcare system, high pet healthcare awareness, and increasing demand for convenient diagnostic testing continue to support market growth.
India's expanding veterinary healthcare infrastructure, growing companion animal population, and increasing awareness of animal disease diagnosis continue to create opportunities for point of care diagnostics.
The European veterinary point of care diagnostics market accounted for 27.2% of the global market, reaching USD 0.63 billion in 2025, and is projected to grow at a CAGR of 8.95% during the forecast period. Growing companion animal healthcare expenditure, increasing veterinary clinic adoption of rapid testing, and rising awareness of preventive animal healthcare continue to support regional growth.
Germany represents a major European market. Its established veterinary care infrastructure, strong pet healthcare sector, and increasing demand for efficient diagnostic testing continue to support market development.
The United Kingdom's developed veterinary services sector, growing emphasis on animal health, and increasing adoption of rapid diagnostic technologies continue to create opportunities for market growth.
Latin America's veterinary point of care diagnostics market accounted for 5.8% of the global market, reaching USD 0.13 billion in 2025, and is expected to grow at a CAGR of 9.15% during the forecast period. Expanding veterinary services, increasing pet ownership, and growing demand for accessible and rapid animal diagnostics continue to support regional market development.
Brazil represents a major regional market. Its expanding veterinary healthcare sector, growing pet population, and increasing demand for rapid diagnostic testing continue to support market growth.
The Middle East & Africa veterinary point of care diagnostics market accounted for 3.9% of the global market, reaching USD 0.09 billion in 2025, and is anticipated to grow at a CAGR of 8.45% during the forecast period. Improvements in veterinary healthcare infrastructure, rising pet ownership, and increasing awareness of animal health continue to support regional market expansion.
The UAE's developing veterinary healthcare infrastructure, increasing pet ownership, and growing demand for advanced animal healthcare services continue to support point of care diagnostics adoption.
Saudi Arabia's expanding veterinary services, growing focus on animal health, and increasing demand for modern diagnostic technologies continue to create opportunities for market development.
The global veterinary point of care diagnostics market is highly competitive, with leading animal health, veterinary diagnostics, medical technology, and laboratory equipment companies competing through blood chemistry analyzers, hematology analyzers, immunoassay systems, urinalysis solutions, molecular diagnostics, infectious disease testing, and portable diagnostic instruments.
Industry participants are focusing on developing rapid, accurate, portable, and user-friendly diagnostic systems that enable veterinarians to obtain test results directly within clinics and animal care facilities.
IDEXX Laboratories is one of the leading companies in the global veterinary point of care diagnostics market, providing diagnostic instruments, consumables, laboratory services, and software solutions for companion animal and other veterinary practices. Its portfolio includes hematology and chemistry analyzers, immunoassays, urinalysis systems, infectious disease testing, and connected diagnostic technologies designed to support rapid clinical decision-making.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Veterinary Pharmaceutical Drugs Market Size, Share, Growth, 2034
Veterinary Electrosurgery Market Size, Share, Growth, Analysis, 2034
Fipronil Market Size, Share, Growth, Analysis, Report, 2034
Pet Care Market Size, Share, Growth, Analysis, Report, 2034
Farm Animal Healthcare Market Size, Share, Growth, Analysis, 2034
Canine Atopic Dermatitis Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com